Yael Weintraub
Overview
Explore the profile of Yael Weintraub including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grabovski R, Regev S, Regev S, Matar M, Weintraub Y, Shamir R, et al.
J Pediatr Gastroenterol Nutr
. 2025 Jan;
PMID: 39871722
Objectives: Mucosal healing (MH) is a key therapeutic target in Crohn's disease (CD) and is associated with improved outcomes. While adult studies indicate a positive correlation between serum anti-tumor necrosis...
2.
Weintraub Y, Collen L, Hussey S, Mitrova K, Machta J, Kang B, et al.
Inflamm Bowel Dis
. 2025 Jan;
PMID: 39813158
Background And Aims: Patients with very early-onset inflammatory bowel disease (VEO-IBD), with an age of onset < 6 years, can present with severe manifestations and may require biologic therapy. Infliximab...
3.
Froy O, Weintraub Y
Trends Mol Med
. 2024 Dec;
PMID: 39643520
Inflammatory bowel diseases (IBDs) involve relapsing-remitting immune activation and inflammation. Both immune system activity and digestive tract function exhibit diurnal variations, regulated by the circadian clock. Disruption of this clock...
4.
Faingelernt Y, Birger I, Morgenstern S, Cohen-Sela E, Matar M, Weintraub Y, et al.
J Pediatr Gastroenterol Nutr
. 2024 Nov;
80(1):141-146.
PMID: 39543954
The Nancy Histological Index (NHI) is used to score histologic disease activity in patients with ulcerative colitis (UC). Our goal was to assess the utility of NHI at diagnosis in...
5.
Nachum N, Salomon N, Yerushalmy-Feler A, Weintraub Y, Yogev D, Granot M, et al.
Front Pediatr
. 2024 Oct;
12:1342656.
PMID: 39403348
Background: Curcumin and Qing Dai (QD) are herbal extracts that recently showed efficacy in treating inflammatory bowel disease (IBD). Since 2016, a combination of curcumin with QD (CurQD) has been...
6.
Ben-Tov A, Achler T, Fayngor R, Shamir R, Supino L, Weintraub Y, et al.
J Pediatr Gastroenterol Nutr
. 2024 Oct;
80(1):147-150.
PMID: 39400390
The no-biopsy approach to diagnose celiac disease (CD), introduced in the 2012 European Society for Gastroenterology and Hepatology and Nutrition guidelines, requires an anti-endomysial antibody (EMA) confirmatory serology test following...
7.
Hilewitz D, Yacobovitz S, Reiss-Huss S, Matar M, Weintraub Y, Shouval D, et al.
Clin Exp Dermatol
. 2024 Oct;
50(3):558-563.
PMID: 39400046
Background: Tumour necrosis factor α (TNF-α) inhibitor (TNFi)-induced psoriasiform eruptions are a well-known phenomenon among adults. However, data are limited regarding this reaction in children. Objectives: To describe in paediatric...
8.
Marshanski T, Fanous E, Tal N, Perets T, Matar M, Weintraub Y, et al.
J Pediatr Gastroenterol Nutr
. 2024 Jul;
79(3):564-572.
PMID: 38979682
Objectives: Multiple studies in patients with Crohn's disease (CD) treated with anti-tumor necrosis factor alpha agents have shown that proactive therapeutic drug monitoring (TDM) during the maintenance phase leads to...
9.
Anafy A, Cohen S, Matar M, Shouval D, Shamir R, Weintraub Y
Acta Paediatr
. 2024 Jun;
113(8):1965-1971.
PMID: 38850099
Aim: Although sexual health (SH) impairment and sexually transmitted infections (STI) are occasionally encountered in patients with inflammatory bowel disease (IBD), paediatric gastroenterologists (PedGI) do not often discuss these issues....
10.
Cohen S, Rolandsdotter H, Kolho K, Turner D, Tzivinikos C, Bramuzzo M, et al.
Paediatr Drugs
. 2024 May;
26(5):609-617.
PMID: 38780740
Background And Objectives: Current data on ustekinumab therapy in children with ulcerative colitis (UC) or unclassified inflammatory bowel disease (IBDU) are limited. We aimed to evaluate the effectiveness and safety...